Summary
Medtronic plc announced a significant leadership change in its finance department via an 8-K filing on June 26, 2024. Karen L. Parkhill, Executive Vice President and Chief Financial Officer, has decided to resign from her position, with her departure effective August 2, 2024. This marks the end of her tenure with the company. In response to Ms. Parkhill's departure, Medtronic has appointed Gary Corona as the interim Chief Financial Officer, effective August 2, 2024. Mr. Corona currently serves as Senior Vice President, Global Financial Planning and Analysis and has been with Medtronic since January 2023. He brings extensive experience from his previous 26-year tenure at General Mills, Inc. The company has also furnished a press release detailing these changes, which is attached as an exhibit to the filing.
Key Highlights
- 1Karen L. Parkhill, EVP and CFO, is resigning effective August 2, 2024.
- 2Gary Corona has been appointed as interim Chief Financial Officer, effective August 2, 2024.
- 3Mr. Corona is currently Senior Vice President, Global Financial Planning and Analysis.
- 4Mr. Corona has extensive financial experience, including 26 years at General Mills.
- 5There are no disclosed arrangements or understandings regarding Mr. Corona's selection for the interim role.
- 6Mr. Corona's compensation arrangements will not change upon his appointment as interim CFO.
- 7A press release announcing these changes was filed as an exhibit.